Clinical trial
PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a…
NCT00250172 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00250172 |
|---|---|
| Title | PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram |
| Official title | PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Dosimetry, Healthy |
| Intervention type | Drug |
| Interventions | [C-11](R)-rolipram |
| Enrollment | 26 |
| Start date | Oct 31, 2005 |
| Primary completion | Feb 5, 2009 |
| Completion | Feb 5, 2009 |
| First posted | Nov 7, 2005 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: